| 产品名称: | Proteus mirabilis Hauser |
|---|---|
| 商品货号: | TS182266 |
| Strain Designations: | 9 |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried |
| Storage Conditions: | 2°C to 8°C |
| Preceptrol®: | no |
| Type Strain: | no |
| Comments: | Parent strain of Proteus mirabilis L-Phase variant L9 (ATCC 14168) |
| Medium: | ATCC® Medium 251: Veal infusion broth with 15% inactivated rabbit serum |
| Growth Conditions: | Temperature: 37°C
Atmosphere: Aerobic |
| Name of Depositor: | RG Wittler |
| Chain of Custody: | ATCC |
| References: | Weibull C, Lundin BM. Factors influencing the growth of a stable L form of Proteus mirabilis. J. Bacteriol. 81: 812-818, 1961. PubMed: 13783770 Hill LR. An index to deoxyribonucleic acid base compositions of bacterial species. J. Gen. Microbiol. 44: 419-437, 1966. PubMed: 5339419 Rogul M, et al. Nucleic acid homologies of selected bacteria, L forms, Mycoplasma species. J. Bacteriol. 90: 1200-1204, 1965. PubMed: 5848325 Cohen RL, et al. Modified biochemical tests for characterization of L-phase variants of bacteria. Appl. Microbiol. 16: 1655-1662, 1968. PubMed: 4302280 |